RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+20.34%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.16B
AUM Growth
+$4.16B
(+7.4%)
Cap. Flow
+$89.8M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
34.47%
Holding
128
New
1
Increased
41
Reduced
25
Closed
8
Top Buys
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$42.5M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$30.5M |
| 3 |
Baxter International
BAX
|
$20.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$16.5M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$15.5M |
Top Sells
| 1 |
CVET
Covetrus, Inc. Common Stock
CVET
|
$35.1M |
| 2 |
Talphera
TLPH
|
$13.6M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$13.4M |
| 4 |
Arvinas
ARVN
|
$12.5M |
| 5 |
OHPAU
Orion Acquisition Corp. Unit
OHPAU
|
$9.87M |
Sector Composition
| 1 | Healthcare | 97.81% |
| 2 | Consumer Staples | 0.83% |
| 3 | Industrials | 0.36% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Humana
HUM
$36.5B
| $218M | 5.26% | 426,500 | – | – |
|
2
Immunocore
IMCR
$1.62B
| $190M | 4.56% | 3,321,066 -172,677 | -5% | -$9.85M |
|
3
Insulet
PODD
$23.9B
| $154M | 3.71% | 524,250 +5,750 | +1% | +$1.69M |
|
4
UnitedHealth
UNH
$281B
| $143M | 3.44% | 270,000 +500 | +0.2% | +$265K |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $134M | 3.23% | 1,122,500 | – | – |
|
6
argenx
ARGX
$43.6B
| $133M | 3.19% | 350,000 | – | – |
|
7
Agilon Health
AGL
$530M
| $127M | 3.06% | 7,872,500 +125,000 | +2% | +$2.02M |
|
|
RXDX
8
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $113M | 2.73% | 1,031,550 +386,143 | +60% | +$42.5M |
|
9
Penumbra
PEN
$10.6B
| $113M | 2.72% | 508,250 +32,250 | +7% | +$7.17M |
|
10
Evolent Health
EVH
$1.12B
| $107M | 2.57% | 3,803,500 +541,000 | +17% | +$15.2M |
|
11
Madrigal Pharmaceuticals
MDGL
$9.76B
| $101M | 2.43% | 348,121 +30,636 | +10% | +$8.89M |
|
12
Idexx Laboratories
IDXX
$51.8B
| $84.7M | 2.04% | 207,500 -16,815 | -7% | -$6.86M |
|
|
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $84.2M | 2.03% | 739,700 +12,700 | +2% | +$1.45M |
|
14
Agios Pharmaceuticals
AGIO
$2.19B
| $84.1M | 2.02% | 2,996,592 -61,277 | -2% | -$1.72M |
|
|
BPMC
15
DELISTED
Blueprint Medicines
BPMC
| $82.9M | 1.99% | 1,891,510 +353,315 | +23% | +$15.5M |
|
|
KRTX
16
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $81.3M | 1.96% | 413,762 | – | – |
|
17
Intuitive Surgical
ISRG
$170B
| $79.2M | 1.91% | 298,500 | – | – |
|
|
CERE
18
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $79.1M | 1.9% | 2,506,464 +7,316 | +0.3% | +$231K |
|
19
Alnylam Pharmaceuticals
ALNY
$58.5B
| $79M | 1.9% | 332,500 | – | – |
|
20
Akero Therapeutics
AKRO
$3.74B
| $76.8M | 1.85% | 1,400,654 +30,681 | +2% | +$1.68M |
|
21
Acadia Healthcare
ACHC
$2.12B
| $69.6M | 1.67% | 845,500 +500 | +0.1% | +$41.2K |
|
22
Align Technology
ALGN
$10.3B
| $63.8M | 1.53% | 302,350 -41,650 | -12% | -$8.78M |
|
23
Aclaris Therapeutics
ACRS
$209M
| $62.4M | 1.5% | 3,961,249 | – | – |
|
24
Ultragenyx Pharmaceutical
RARE
$2.89B
| $59.8M | 1.44% | 1,290,279 +102,287 | +9% | +$4.74M |
|
|
25
Baxter International
BAX
$12.7B
| $58.6M | 1.41% | 1,150,000 +394,500 | +52% | +$20.1M |
|